Evidence for the Use of Epoprostenol to Treat Raynaud’s Phenomenon With or Without Digital Ulcers

  title={Evidence for the Use of Epoprostenol to Treat Raynaud’s Phenomenon With or Without Digital Ulcers},
  author={Joseph E Cruz and A. Ward and Shannon Anthony and S. Chang and Hyun Bae and E. Hermes-DeSantis},
  journal={Annals of Pharmacotherapy},
  pages={1060 - 1067}
  • Joseph E Cruz, A. Ward, +3 authors E. Hermes-DeSantis
  • Published 2016
  • Medicine
  • Annals of Pharmacotherapy
  • Objective: To review the evidence for using intravenous (IV) epoprostenol to treat Raynaud’s phenomenon (RP). Data Sources: The databases MEDLINE (1946 to March 2016), PubMed, and International Pharmaceutical Abstracts were searched using the terms epoprostenol, Flolan, Raynaud’s disease, and CREST syndrome. Further literature sources were identified by reviewing article citations. Study Selection and Data Extraction: All English-language, clinical trials and case series evaluating IV… CONTINUE READING
    6 Citations
    Pharmacotherapy Options in the Management of Raynaud’s Phenomenon
    • 5
    Evidence-based management of Raynaud’s phenomenon
    • A. Herrick
    • Medicine
    • Therapeutic advances in musculoskeletal disease
    • 2017
    • 6
    Raynaud's phenomenon.
    • 23
    Raynaud’s phenomenon


    Management of Raynaud’s Phenomenon and Digital Ischemia
    • A. Herrick
    • Medicine
    • Current Rheumatology Reports
    • 2012
    • 44
    • Highly Influential
    New lines in therapy of Raynaud’s phenomenon
    • 21
    • PDF
    Diagnosis and management of Raynaud’s phenomenon
    • 71
    Calcium channel blockers for primary Raynaud's phenomenon.
    • 21
    • PDF
    International consensus criteria for the diagnosis of Raynaud's phenomenon.
    • 115
    • PDF
    Successful treatment of Raynaud's Syndrome with prostacyclin.
    • 51